Navigation Links
Researchers investigate a less toxic radiation treatment for HPV-Positive oropharynx cancer
Date:5/31/2013

CHICAGO, IL (May 29, 2013)Researchers from Fox Chase Cancer Center and other institutions have completed a phase II clinical trial that may help identify those patients with HPV-positive oropharyngeal cancer who do not require the full radiation dose given in a standard regimen of Intensity-Modulated Radiation Therapy (IMRT). Preliminary findings will be presented by Shanthi Marur, first author on the study and an oncologist at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, at the 49th Annual Meeting of the American Society of Clinical Oncology on Sunday, June 2.

Patients enrolled in the trial received an initial regimen of chemotherapy followed by treatment with the targeted therapy cetuximab, a monoclonal antibody. In the study, a patient's response to those initial treatments determined the dose during radiation treatment.

"Those patients who had a really good response to chemotherapy might also be more responsive to radiation," says Barbara Burtness, senior author on the study and chief of head and neck medical oncology at Fox Chase. "Therefore, the use of a full dose of radiation for those patients might represent overtreatment."

Burtness is also chair of the Eastern Cooperative Oncology Group (ECOG), which sponsors this ongoing trial. ECOG is a a National Cancer Institute-funded team of researchers who organize and carry out clinical trials.

According to the National Cancer Institute, more than 40,000 people will be diagnosed with cancer of the oropharynxa swath of tissue at the back of the throatin 2013, and nearly 8,000 will die from the disease. Between 60 and 80 percent of cases are associated with infection by Human Papilloma Viruses, or HPVs.

"Patients with HPV-associated oropharyngeal cancer tend to be younger than other oropharyngeal cancer patients, and would be living with the aftereffects of treatment for more years," says Burtness. A patient who undergoes standard radiation to th
'/>"/>

Contact: Diana Quattrone
diana.quattrone@fccc.edu
215-815-7828
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Researchers discover new weapon in fight against cervical cancer
2. Researchers gain insight into key protein linked to cancers, neurodegenerative disorders
3. Researchers identify novel approach to create red blood cells, platelets in vitro
4. Researchers shed new light on egg freezing success rates
5. Junk DNA plays active role in cancer progression, researchers find
6. Researchers provide rationale for use of targeted immunotherapy in sarcomatoid lung carcinomas
7. Stanford researchers identify genetic suspects in sporadic Lou Gehrigs disease
8. Researchers identify first drug targets in childhood genetic tumor disorder
9. Researchers find common childhood asthma unconnected to allergens or inflammation
10. Researchers identify networks of neurons in the brain that are disrupted in psychiatric disease
11. Fish Oil Pills Might Cut Diabetes Risk, Researchers Say
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... SAN DIEGO, May 27, 2015 – ... first healthcare provider along the Gulf Coast to ... (CCM). In partnership with MD Revolution, a digital ... new program that enables healthcare providers to easily ... This new, user-friendly program is designed to improve ...
(Date:5/27/2015)... CA (PRWEB) May 27, 2015 Coco Libre ... will be able to reach for Organic Coconut Water to ... Libre will be available at VIP areas, artist greenrooms, corporate ... be available at area hotels and on festival shuttle buses. ... partner this year,” said Noa Elan, Director of Strategic Partnerships ...
(Date:5/27/2015)... This is a professional and ... Omega-3 industry. The report provides a basic overview ... industry chain structure. The Omega-3 market analysis is ... competitive landscape analysis, and key regions development status. ... Company, Seadragon Marine Oils, Norwegian Fish Oil, Croda ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 With InnerVoice ... communication environment where the message is not only heard but ... drawing, or virtually any motivating image. This award-winning and affordable ... offer. , Now, using InnerVoice Sender app ... be sent to a learner remotely for no additional cost. ...
(Date:5/27/2015)... Valley, CA (PRWEB) May 27, 2015 For ... Dr. Peyman Ghasri, is now offering discounts on facial fillers. ... year after the age of 18. This lost collagen can ... sunken cheeks, wrinkles and expression lines. Facial fillers are an ... Many people turn to facial fillers to create a softer ...
Breaking Medicine News(10 mins):Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Discounts on Facial Fillers 2
... Philippines is witness to a yearly exodus phenomenon of ... their land for raking// in the moolah elsewhere! This ... against serious implications on the country’s health services. According ... grave with nearly 85% of the nursing population, settled ...
... the spread of the potentially fatal mosquito-borne disease, Murray ... Pilbara. ,The continuing wet season in Kimberley ... (MVE). The cyclone Glenda along with the more recent ... ,The Department of Health has warned people living and ...
... the issue of International Journal of Cancer has stated ... cancer in women//. ,According to foodconsumer.org, the ... Studies of Cervical Cancer, found that current smokers were ... those who never smoked. ,In addition, researchers ...
... the construction abilities of tiny viruses to build "nanowire" ... , MIT Professors Angela Belcher, Paula Hammond ... genes within common laboratory virus strains were able to ... electronic device. ,Batteries are made of two ...
... a 100 middle and primary school students in the county ... ricin early on Thursday. //The state media reported that the ... castor beans that they ate. ,The magistrate of ... were taking part in a bean planting activity, which was ...
... Nearly three fourth of the African population still hold ... have expressed interest in the abundant resources //of the ... of new drugs. This would obviously call for a ... traditional knowledge and facilitate fairness in its dissemination. ...
Cached Medicine News:
(Date:5/27/2015)... OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts ... a series of diverse complications arising from the presence ... tissues, which cause a rapidly progressing hyperactive host immune ... 50% depending on disease severity. The syndrome places a ... global marketplace, which for the purposes of this report ...
(Date:5/27/2015)... 2015 PharmaPoint: Type 1 Diabetes - Global Drug ... 1 diabetes (T1D) is an autoimmune disease that permanently destroys ... body can no longer produce insulin. Over the last 90 ... no other treatment can be offered to a patient who ... with different times of action - long-acting as well as ...
(Date:5/27/2015)... PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis ... - Event-Driven Update Summary The lupus ... is the only drug that has gained marketing approval ... launch, patients, uptake has remained low, but due to ... the lupus market in terms of value and is ...
Breaking Medicine Technology:OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 3OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 4PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 2PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 3
... HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Jul 3, 2007 - ... clinical results from the Company's studies of ... presented at the New,England Section of the ... The paper is authored by leading clinical,research ...
... Australia--(BUSINESS WIRE)--Jul 5, 2007 - Australian,biotechnology company Avexa ... blinded phase which,represents the first 24 week segment ... into the open-label section of the,trial (weeks 24 ... twice a day as part of their daily ...
Cached Medicine Technology:Clinical Data From Nymox BPH Drug To Be Presented at American,Urological Association Meeting 2Avexa's Apricitabine Clinical Trial Update 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: